Pierluigi Antonelli

Corporate Officer/Principal at FRESENIUS SE & CO. KGAA

Health Technology

Consumer Services

Finance

Profile

Pierluigi Antonelli is currently the Chief Executive Officer-Fresenius Kabi at Fresenius SE & Co. KGaA. He is also the President & Chief Executive Officer at Fresenius Kabi AG and the Chief Executive Officer at Fresenius Kabi.
Previously, he held the position of Chief Executive Officer at Aziende Chimiche.
Riunite Angelini Francesco - A.C.R.A.F.
- SpA and Angelini Pharma, Inc. From 2019 to 2023, he served as the Chief Executive Officer at Angelini Pharma SpA. He was also the European Vice President & Managing Director-Italy at Bristol-Myers Squibb GmbH & Co. KGaA and the Head-Europe Novartis Oncology at Sandoz Deutschland GmbH from 2015 to 2019.
Prior to that, he worked as an Engagement Manager at Mckinsey & Co., Inc. (Munich) from 1994 to 1998 and as a Senior Vice President-Italy at Merck & Co. Mr. Antonelli holds an MBA from Northwestern University, which he obtained in 1994.
He also completed his undergraduate studies at The LUISS University of Rome in 1989.

Pierluigi Antonelli active positions

Companies	Position	Start
FRESENIUS SE & CO. KGAA	Corporate Officer/Principal	28/02/2023
Fresenius Kabi AG Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases	Chief Executive Officer	-
Fresenius Kabi	Chief Executive Officer	-

All active positions of Pierluigi Antonelli

Former positions of Pierluigi Antonelli

Companies	Position	End
Angelini Pharma SpA Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs	Chief Executive Officer	05/02/2023
Sandoz Deutschland GmbH Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company	Corporate Officer/Principal	31/12/2018
Mckinsey & Co., Inc. (Munich)	Corporate Officer/Principal	31/12/1997
Bristol-Myers Squibb GmbH & Co. KGaA Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines	Corporate Officer/Principal	-
Merck & Co. Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings	Corporate Officer/Principal	-

See the detail of Pierluigi Antonelli's experience

Training of Pierluigi Antonelli

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pierluigi Antonelli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices	Health Services
Fresenius Kabi AG Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases	Health Technology
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Northwestern University Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The LUISS University of Rome The LUISS University of Rome Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fresenius Kabi
Sandoz Deutschland GmbH Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company	Finance
Bristol-Myers Squibb GmbH & Co. KGaA Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines	Health Technology
Mckinsey & Co., Inc. (Munich)
Angelini Pharma, Inc. Angelini Pharma, Inc. Specialty StoresRetail Trade Operates as a medical supply store	Retail Trade
Merck & Co. Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings	Finance
Angelini Pharma SpA Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs	Health Technology